Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03475953
Title A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Institut Bergonie
Indications

stomach carcinoma

hepatobiliary system cancer

hepatocellular carcinoma

esophageal carcinoma

differentiated thyroid gland carcinoma

lung non-squamous non-small cell carcinoma

gastrointestinal stromal tumor

lung non-small cell carcinoma

Advanced Solid Tumor

neuroendocrine tumor

colorectal cancer

Therapies

Avelumab + Regorafenib

Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST